Related Drugs: Adrenalin, adyphren, adyphren amp, Adyphren Amp Ii, Adyphren Ii, Epinephrine Professional Ems, Epinephrine Professional Kit, Epinephrinesnap, Epinephrinesnap-Ems, Epinephrinesnap-V, Epipen, Epipen JR
FDA Alert: On March 23rd, 2020, the drug manufacturer and marketer of EpiPen, Pfizer and Mylan, announced in a letter to patients, caregivers, and providers that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, including the authorized generic versions, may not work due to:
• “Device failure from spontaneous activation caused by using sideways force to remove the blue safety release
• Device failure from inadvertent or spontaneous activation due to a raised blue safety release
• Device failure from inadvertent or spontaneous activation due to a raised blue safety release
• Difficulty removing the device from the carrier tube”
There is no recall established at the time of this writing. You can visit the FDA website for the most up to date information regarding this EpiPen alert.
FDA Alert: On March 23rd, 2020, the drug manufacturer and marketer of EpiPen, Pfizer and Mylan, announced in a letter to patients, caregivers, and providers that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, including the authorized generic versions, may not work due to:
• “Device failure from spontaneous activation caused by using sideways force to remove the blue safety release
• Device failure from inadvertent or spontaneous activation due to a raised blue safety release
• Device failure from inadvertent or spontaneous activation due to a raised blue safety release
• Difficulty removing the device from the carrier tube”
There is no recall established at the time of this writing. You can visit the FDA website for the most up to date information regarding this EpiPen alert.